Published in BMC Public Health on June 05, 2014
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med (2007) 15.40
Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis (2010) 5.39
Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ (2008) 3.32
Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ (2011) 2.95
Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis (2012) 2.51
Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ (2012) 2.20
Human papillomavirus vaccine introduction--the first five years. Vaccine (2012) 2.12
Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings. Arch Pediatr Adolesc Med (2009) 1.78
Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell Q Rep (2008) 1.40
Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis (2012) 1.38
Strategies to vaccinate against cancer of the cervix: feasibility of a school-based HPV vaccination program in Peru. Vaccine (2011) 1.36
HPV & HPV vaccination: issues in developing countries. Indian J Med Res (2009) 1.35
Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam. Bull World Health Organ (2013) 1.25
Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008. Vaccine (2008) 1.24
Chapter 15: HPV vaccine use in the developing world. Vaccine (2006) 1.23
A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania. Vaccine (2012) 1.22
Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis (2012) 1.18
Assessment of eight HPV vaccination programs implemented in lowest income countries. BMC Public Health (2012) 1.16
Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings. Vaccine (2009) 1.14
HPV vaccine in Rwanda: different disease, same double standard. Lancet (2011) 1.09
Human papillomavirus vaccine introduction in Vietnam: formative research findings. Sex Health (2010) 1.07
Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: an in-depth qualitative study post-vaccination. BMC Public Health (2012) 1.00
HPV vaccination in France: uptake, costs and issues for the National Health Insurance. Vaccine (2011) 1.00
Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark. Vaccine (2011) 0.99
National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program. Sex Health (2010) 0.98
'It's a logistical nightmare!' Recommendations for optimising human papillomavirus school-based vaccination experience. Sex Health (2010) 0.95
Inter-state variation in human papilloma virus vaccine coverage among adolescent girls in the 50 US states, 2007. Matern Child Health J (2012) 0.88
Initial lessons learned in HPV vaccination. Gynecol Oncol (2008) 0.86
Assessment of the first HPV vaccination campaign in two northern Italian health districts. Vaccine (2011) 0.85
Human papilloma virus vaccination for control of cervical cancer: a challenge for developing countries. Afr J Reprod Health (2011) 0.78
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis (2012) 8.02
Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis (2006) 3.96
Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ (2011) 2.95
Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis (2009) 2.89
Cholera outbreaks caused by an altered Vibrio cholerae O1 El Tor biotype strain producing classical cholera toxin B in Vietnam in 2007 to 2008. J Clin Microbiol (2009) 2.16
Population-level antibody estimates to novel influenza A/H7N9. J Infect Dis (2013) 2.03
Use of oral cholera vaccines in an outbreak in Vietnam: a case control study. PLoS Negl Trop Dis (2011) 1.89
The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007-2010: the Ha Nam household cohort study I. Am J Epidemiol (2012) 1.67
Quantifying the emergence of dengue in Hanoi, Vietnam: 1998-2009. PLoS Negl Trop Dis (2011) 1.48
Human immunodeficiency virus (HIV) infection patterns and risk behaviours in different population groups and provinces in Viet Nam. Bull World Health Organ (2007) 1.43
Multilocus variable-number tandem repeat analysis of Vibrio cholerae O1 El Tor strains harbouring classical toxin B. J Med Microbiol (2010) 1.42
Influenza infection rates, measurement errors and the interpretation of paired serology. PLoS Pathog (2012) 1.38
Strategies to vaccinate against cancer of the cervix: feasibility of a school-based HPV vaccination program in Peru. Vaccine (2011) 1.36
Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam. Virology (2009) 1.36
HIV risk behaviours and determinants among people living with HIV/AIDS in Vietnam. AIDS Behav (2008) 1.26
Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial. JAMA (2011) 1.12
Human papillomavirus vaccine introduction in Vietnam: formative research findings. Sex Health (2010) 1.07
Identification of H5N1-specific T-cell responses in a high-risk cohort in vietnam indicates the existence of potential asymptomatic infections. J Infect Dis (2011) 1.05
Surveillance for Japanese encephalitis in Vietnam, 1998-2007. Am J Trop Med Hyg (2010) 1.05
Classification of hybrid and altered Vibrio cholerae strains by CTX prophage and RS1 element structure. J Microbiol (2010) 1.03
Acceptance patterns and decision-making for human papillomavirus vaccination among parents in Vietnam: an in-depth qualitative study post-vaccination. BMC Public Health (2012) 1.00
Litchi-associated acute encephalitis in children, Northern Vietnam, 2004-2009. Emerg Infect Dis (2012) 1.00
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains containing New Delhi metallo-beta-lactamase isolated from two patients in Vietnam. J Clin Microbiol (2012) 0.97
Epidemiology of a measles epidemic in Vietnam 2008-2010. J Infect Dis (2011) 0.97
Modelling the progression of pandemic influenza A (H1N1) in Vietnam and the opportunities for reassortment with other influenza viruses. BMC Med (2009) 0.91
Migration and persistence of human influenza A viruses, Vietnam, 2001-2008. Emerg Infect Dis (2013) 0.88
Surveillance of transmitted HIV drug resistance using matched plasma and dried blood spot specimens from voluntary counseling and testing sites in Ho Chi Minh City, Vietnam, 2007-2008. Clin Infect Dis (2012) 0.85
Household survey in two provinces in Viet Nam estimates HIV prevalence in an urban and a rural population. AIDS Res Hum Retroviruses (2008) 0.84
Investigation of dengue and Japanese encephalitis virus transmission in Hanam, Viet Nam. Am J Trop Med Hyg (2014) 0.77
Should the ideal be the enemy of the good? J R Soc Med (2012) 0.76
Reconsidering the feasibility of papanicolaou and alternative screening tests for low-resource countries. Am J Public Health (2006) 0.76
Short communication: phylogenetic characterization of HIV type 1 CRF01_AE V3 envelope sequences in pregnant women in Northern Vietnam. AIDS Res Hum Retroviruses (2011) 0.76
Human papillomavirus vaccine inaccuracies. Am J Public Health (2012) 0.75
Effect of the "cough technique" on cryotherapy freezing temperature. Int J Gynaecol Obstet (2009) 0.75
Performance of cryotherapy devices using nitrous oxide and carbon dioxide. Int J Gynaecol Obstet (2010) 0.75